Anti-ROR1 antibodies and preparation method and uses thereof
AssigneeNanjing Immunophage Biotech Co., Ltd.
InventorsGuohuang Fan, Jianfei Wang
Life of this patent
Estimating the term…
Abstract
The present invention relates to anti-ROR1 antibodies and to methods of using anti-ROR1 antibodies. The anti-ROR1 antibodies described herein are useful for the diagnosis and treatment of diseases, such as various cancers, associated with aberrant expression of ROR1.
Claims20
An isolated monoclonal antibody or antigen-binding fragment thereof which comprises a heavy chain complementarity determining region 1 (HCDR1), HCDR2, HCDR3, a light chain complementarity determining region1 (LCDR1), LCDR2, and LCDR3, wherein the polypeptide sequences of HCDR1, HCDR2, HCDR3, LCDR1, LCDR2, and LCDR3 are selected from the group consisting of:
- a. SEQ ID NOs:
- 2, 3, 4, 6, 7 and 8, respectively;
- or
- b. SEQ ID NOs:
- 16, 17, 18, 20, 21 and 22, respectively;
- or
- c. SEQ ID NOs:
- 30, 31, 32, 34, 35 and 36, respectively;
- d. SEQ ID NOs:
- 9, 10, 11, 12, position 1-2 of SEQ ID No:
- 13, and SEQ ID No:
- 14;
- or
- e. SEQ ID NOs:
- 23, 24, 25, 26, position 1-2 of SEQ ID No:
- 27, and SEQ ID No:
- 28, respectively;
- or
- f. SEQ ID NOs:
- 37, 38, 39, 40, position 1-2 of SEQ ID No:
- 41, and SEQ ID No:
- 42, respectively;
- wherein the antibody or antigen-binding fragment thereof specifically binds ROR1.
Dependencies are inferred from the claim text.